Studies in prostate and colorectal cancer cells have demonstrated that the over-expression of NDRG1 inhibited TGF-β-induced EMT by inhibiting SMAD2 and pSMAD3 expression, which are key signaling molecules involved in the TGF-β/SMAD pathway [36,82]. The gene discussed is TGFB1; the disease is colorectal cancer.